治疗剂量肝素对因COVID-19住院患者的异质治疗效应
在PubMed上查看摘要
概括
此摘要是机器生成的。治疗剂量的肝素在COVID-19患者中表现出不同的效果. 它有利于较少的病人,但伤害更严重的病人,强调需要在临床决策中考虑治疗效果的异质性.
科学领域
- 危急护理医学
- 药理学
- 流行病学
背景情况
- 对住院COVID-19患者的治疗剂量肝素的随机临床试验 (RCT) 产生了相互矛盾的结果.
- 治疗效果的异质性 (HTE) 可能解释这些差异,需要个性化治疗策略.
研究的目的
- 在住院COVID-19患者中调查治疗剂量肝素的HTE.
- 在临床试验中比较评估HTE的不同方法.
主要方法
- 涉及3320名COVID-19患者的多平台适应性RCT的探索性分析.
- 使用分组分析,基于风险的预测模型和基于效果的因果森林模型评估HTE.
- 使用贝叶斯统计学进行初级分析.
主要成果
- 在整体RCT群体中,治疗剂量的肝素并没有改善无器官支持的日期.
- 在不太严重的患者和低BMI患者中观察到HTE,有好处.
- 患病的患者和BMI较高的患者表现出治疗剂量肝素的危害风险增加.
结论
- 治疗剂量肝素在COVID-19中的疗效是异质的,根据患者的疾病严重程度和BMI而异.
- 这些发现强调了在RCT设计和患者管理中考虑HTE的重要性.
- 个性化治疗方法对于优化COVID-19的肝素治疗至关重要.
相关概念视频
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

